Dr Lal Pathlabs announces acquisition of two pathology labs
Capital MarketDr Lal Pathlabs announced that its wholly owned subsidiary, PathLabs Unifiers has signed binding term sheets on 6 November, 2020 for
the acquisitions of the business of Bindish Diagnostic Laboratory LLP (BDL), in Jamnagar, Gujarat on a going concern basis, for a purchase consideration not exceeding Rs 4 crore and equity stake of 70% in ChanRe Diagnostic Services (CDSPL), in Bengaluru, Karnataka, for a purchase consideration not exceeding Rs 17.5 crore. BDL and CDSPL are
engaged in the business of providing pathological diagnostic services
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
